Filings (90d)
Other insiders active in the same sector
No other insider has filed at Slate Path Capital LP's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Slate Path Capital LP?
Slate Path Capital LP is an investment firm, tracked as 10% Owner of Cyclerion Therapeutics, Inc. (CYCN). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Slate Path Capital LP last file a Form 4?
The only primary Form 4 on record is dated 25 November 2024.
Has Slate Path Capital LP been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($555K) across all tracked filings.
